Skip to content

Public FDA record

Z-1151-2021: The PrisMax System Version II Hemodialysis Delivery System: Automatic Repositioning System Pump Assembly,

Recall record Z-1151-2021 for Baxter Healthcare Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1151-2021
Company in FDA record
Baxter Healthcare Corporation
FDA record creation date
Feb 26, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Variability in the performance of the tubing in the ARPS (Automatic Repositioning System) Pump Assembly which may lead to alarm situations during system self-test and therapy. This tubing is normally replaced during annual preventative maintenance. Alarm Situations: During System Self-Test: Alarm code B1215 (ARPS Self-Test failure); During Therapy: B1273 (ARPS Leak), B1215 (ARPS Pressure self-test), B1116 (Return Pressure self-test Failure), B1539 (Access Pod Reposition Failure), B1541 (Effluent Pod Reposition Failure), B1540 (Effluent Filter Pod Reposition Failure). If an alarm occurs, it may lead to delay or interruption of therapy. In the event that therapy is terminated without returning blood to the patient, blood loss may occur.

Source facts

Action
Baxter sent An Urgent Medical Device Correction letter dated January 7, 2021. To prevent potential alarm situations, the affected tubing in the ARPS Pump Assembly for the PrisMax devices will be replaced with improved tubing. Operators may continue to safely use the PrisMax System until the tubing is replaced within the ARPS Pump Assembly. If an alarm occurs, the PrisMax System will default to a safe state and the user should follow the on-screen instructions to end treatment and to contact service. A local Baxter service representative will contact each facility to determine the correction plan and schedule the replacement for the impacted devices only. Facilities involved will be receiving this replacement from Baxter at no charge. If you received this communication directly from Baxter, complete the enclosed Baxter Customer Reply Form and return it to Baxter by e-mailing it to fca@baxter.com. Returning the customer reply form promptly will confirm your receipt of this notification and prevent you from receiving repeat notices. If you do not return the customer reply form, you will receive a phone call from OnProcess Technology on behalf of Baxter to confirm your receipt of this notification. If you purchased this product from a distributor, please note that the Baxter customer reply form is not applicable. If a reply form is provided by your distributor or wholesaler, please return it to the supplier according to their instructions. If you distribute this product to other facilities or departments within your institution, please forward a copy of this communication to them. If you are a dealer, wholesaler, distributor/reseller, or original equipment manufacturer (OEM) that distributed any affected product to other facilities, please notify your customers of this Urgent Medical Device Correction in accordance with your customary procedures and check the associated box on the reply form. For general questions regarding this communication, contact Baxter Corporate
Initiated
2021-01-07
Root cause
Under Investigation by firm
Terminated
2024-04-30
Distribution
Worldwide distribution - US Nationwide distribution including in the states of AR, AZ, CA, CO, CT, FL, GA, HI, IL, IN, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, NH, NJ, NM, NY, OH, OR, PA, SD, TN, TX, UT, VA, WA, WI and the countries of Australia, Austria, Belgium, Canada, China, Croatia, Denmark, Finland, France, Germany, Israel, Italy, Japan, Jordan, Kenya, Korea (Republic Of), Kuwait, Lithuania, Malaysia, Malta, Mexico, Morocco, Netherlands, New Zealand, Norway, Poland, Spain, Sweden, United Kingdom.
Recall number
Z-1151-2021
Recall status
Terminated
CDRH record ID
185435
FDA record created
2021-02-26
Recall event number
87147

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗